Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
75 participants
OBSERVATIONAL
2015-03-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Symptom Support During Chemotherapy: A Mixed Method Study in Adult Patients With Cancer
NCT02298972
Evidence-Based Nursing for Psychological Resilience in Lung Cancer Chemotherapy Patients
NCT07049250
CAncer, NUtrition and Taste 2
NCT05027490
Psychological Factors Influencing Cancer Post-traumatic Growth
NCT06278558
Perceptions of Touch in People With Cancer
NCT00631735
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objective of the research:
To determine the perceptions and representations of chemotherapy, its physical impacts, psychological and relational.
To qualitatively compare the performances of chemotherapy as it has an end as scheduled for adjuvant chemotherapy, or endless precise as in the palliative chemotherapy
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients requiring lung cancer chemotherapy
30 major Patients with lung cancer requiring chemotherapy either as palliative or adjuvant as surgical treatment having a semi-structured interview conducted by a clinical psychologist
semi-structured interview conducted by a clinical psychologist
semi-structured interview conducted by a clinical psychologist
Family of lung cancer patients receiving chemotherapy
30 Family of lung cancer patients receiving chemotherapy having a semi-structured interview conducted by a clinical psychologist
semi-structured interview conducted by a clinical psychologist
semi-structured interview conducted by a clinical psychologist
doctors caring for lung cancer patients receiving chemotherapy
15 doctors caring for lung cancer patients receiving chemotherapy 15 have a semi-structured interview conducted by a psychiatrist specialized in psycho-oncology
semi-structured interview conducted by a psychiatrist specialized in psycho-oncology
semi-structured interview conducted by a psychiatrist specialized in psycho-oncology
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
semi-structured interview conducted by a clinical psychologist
semi-structured interview conducted by a clinical psychologist
semi-structured interview conducted by a psychiatrist specialized in psycho-oncology
semi-structured interview conducted by a psychiatrist specialized in psycho-oncology
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 30 significant others (relatives) major applicant lung cancer patients chemotherapy either palliation or as adjuvant to surgery
* 15 Doctors oncologists performing either chemotherapy as palliative or adjuvant as surgical treatment
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECHMPL16_0208
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.